U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758127) titled 'Updates and Insights on HER2 in Breast Cancer in Sohag Governorate' on Aug. 05. Brief Summ... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07756684) titled 'Feasibility of Cough Skill Training in Individuals With Head and Neck Cancer' on Aug. 07. ... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758231) titled 'Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics' on Aug. 05. Brief Su... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757971) titled '2D:4D Ratio in Relation to Anxiety and Stress Among Anesthesiology Residents' on Aug. 03. ... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758088) titled 'Dance, Yoga, And Mindful Movement Training For ASD' on Aug. 05. Brief Summary: The goal of... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758114) titled 'Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)' on Aug. 05. ... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07759089) titled 'The Efficacy of Tranexamic Acid and Adrenaline to Control Endobronchial Bleeding' on July 3... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758920) titled 'A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of ... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07756710) titled 'Ursodeoxycholic Acid in Barrett's Endotherapy' on Aug. 07. Brief Summary: Barrett's esopha... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757191) titled 'DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric Cancer' o... Read More